Agilon Health, Inc. · NYSE:AGL
Agilon Health — Investor Day (November 2026)
36 slides from Agilon Health's investor day presentation, Nov 17, 2026
Slide 1: Driving Performance At Scale: The agilon Framework
Driving Performance At Scale: The agilon Framework Technology-Enabled Clinical and Quality Programs to Advance Patient Outcomes November 17, 2026 Copyright © 2026 agilon health. All rights reserved.
Slide 2: Disclaimers and Forward-Looking Statements
Disclaimers and Forward-Looking Statements FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION Statements in this presentation that are not historical factual statements are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Slide 3: Today's speakers
Today’s speakers Dr. Karthik Rao Varun Anand Dr. Jon Copeland Heidi Hittner Chief Medical Officer Senior Vice Family Physician, Chief Business President, Product & United Physicians Operations Officer Interim Chief Technology Officer Copyright © 2026 agilon health. All rights reserved.
Slide 4: Agenda
Agenda 1. Total Care Model and clinical care – Dr. Karthik Rao 2. Focus areas a. Technology foundation – Varun Anand b. Clinical pathways – Dr. Karthik Rao c. Physician engagement – Dr. Jon Copeland d. Quality programs – Heidi Hittner & Dr. Jon Copeland 3. Q&A Copyright © 2026 agilon health. All rig
Slide 5: Total Care Model and clinical care
Total Care Model and clinical care Dr. Karthik Rao Chief Medical Officer, agilon health Copyright © 2026 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Slide 6: Scale of the Total Care Model
01 | Scale of the Total Care Model Scaled VBC partner driving primary care physician success ~30 ~2,200 500K+ ~$6B Markets Primary Care Medicare Total Medical Nationwide1 Physicians1 Patients1 Expense Managed1 Deep, embedded relationships with physician partners Scalable capabilities across markets
Slide 7: agilon health Total Care Model
agilon health Total Care Model Four integrated capabilities, one physician-led model Partnership agilon works side-by-side with local primary care physicians to transform their practices to improve care for Medicare patients. Partnership Network PCPs from across the Network to actively engage with e
Slide 8: The problem we solve
The problem we solve Primary care physicians face mounting strain as multiple chronic conditions also drive most of Medicare spend Increasing Strain on Physicians Increasing Spend with Complexity 39% ~$800B Cumulative Change (%) 70% 60% Physicians have 50% seen a ~33% Estimated Medicare Estimated Me
Slide 9: agilon health clinical model
agilon health clinical model BURDEN OF ILLNESS 2 CLINICAL INTERVENTIONS % Seniors in risk stratification category Comprehensive Clinical Fundamentals Appropriate and accurate diagnosis based on avoidable utilization1 high-risk care pathways of value Palliative Care team Priority chronic Care coordin
Slide 10: Focus area: Technology foundation
Focus area: Technology foundation Varun Anand Senior Vice President, Product & Interim Chief Technology Officer, agilon health Copyright © 2026 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Slide 11: Technology drives insights across the network
Technology drives insights across the network CARE DELIVERY ENABLEMENT Insights INTELLIGENCE End-user • A 360° view of each DATA PRODUCTS Analytics & insights technology tools member — stitching The agilon longitudinal payor and Physicians data ecosystem Human Intelligence Point-of-Care Insights pro
Slide 12: Connecting data to care: earlier identification and treatment of high-risk patients
Connecting data to care: earlier identification and treatment of high-risk patients Ingestion Aggregation Financial data from payor partners A comprehensive view of each member combined with practice data and — bringing together information from Outcomes clinical feeds from EMRs1, HIEs2 payors, prov
Slide 13: Insights embedded in the care workflow
Insights embedded in the care workflow PCP PHYSICIAN + OPERATOR GenAI clinical insight Clinical pathways: memos at the point of care Screening to adherence Surfaces relevant clinical Identifies patients eligible for conditions, screening needs, and critical screenings and flags them AI-generated cli
Slide 14: Focus area: Clinical Pathways
Focus area: Clinical Pathways Dr. Karthik Rao Chief Medical Officer, agilon health Copyright © 2026 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Slide 15: One repeatable framework scalable across conditions
One repeatable framework scalable across conditions A structured, end-to-end approach to managing chronic conditions in the primary care setting 1 2 3 4 5 Identify Diagnose Treat Follow Up Outcomes Identification and Appropriate testing is Evidence-based Ongoing monitoring, Measured by earlier strat
Slide 16: An integrated framework for action-oriented patient care
An integrated framework for action-oriented patient care 1 Identify 2 Diagnose 3 Treat 4 Follow-up 5 Outcomes • Pathway definition • Diagnostic criteria and • Surface guideline- • Lab, diagnostic, & visit • Clinical outcomes agilon • Identification & risk recommendations aligned treatment tracking m
Slide 17: Clinical pathway: congestive heart failure (CHF)
Clinical pathway: congestive heart failure (CHF) #1 ~40% $30K+ ~20% Cause of potentially preventable Increase in age-adjusted HF mortality Avg annual cost 30-day readmission hospitalization in Medicare patients1 rate between 2010 and 20232 per CHF patient6 rate (national avg)3 agilon CHF pathway: id
Slide 18: Evidence-based clinical actions across the heart failure pathway
Evidence-based clinical actions across the heart failure pathway to meaningfully improve outcomes and quality of life for patients Treatment Palliative care Diagnosis Underutilized GDMT3 which Underdiagnosed Stage D Identifying 40-50% of leads to unnecessary patients and delays in patients at first
Slide 19: From frequent hospitalizations to renewed independence
From frequent hospitalizations to renewed independence A patient’s journey through enhanced care clinic: HF1 Outcomes • ER visits decreased by 50%. • Depressive symptoms improved as conditions were better controlled • Regained Initial Diagnosis Intervention Follow-Up independence and Retired patient
Slide 20: Heart failure pathway supports proactive diagnosis and optimization of GDMT
Heart failure pathway supports proactive diagnosis and optimization of Guideline-Directed Medical Therapy (GDMT) Virtual pharmacy patients on all four GDMT pillars ~50% ~20% Reduced diagnosis Benchmark 2 agilon 3 of heart failure in % Heart failure patients with reduced an acute setting ejection fra
Slide 21: Clinical pathway: serious illness care (palliative and hospice)
Clinical pathway: serious illness care (palliative and hospice) ~50% 52.9% 74% 71% Fewer hospital admissions with Medicare decedents who Non-hospice cancer patients dying in Americans preferring to die at home, community-based palliative care1 used hospice in 20242 a hospital or facility, vs. 14% wi
Slide 22: Clinical pathway: dementia
Clinical pathway: dementia $105.9B 60% 10% 60% 2025 Medicare costs Dementia cases in the US Estimated U.S. prevalence among Dementia patients who wish diagnosis associated with dementia1 undetected2 adults 65+ (2016 data)3 had come sooner4 agilon Dementia Pathway: Identify → Diagnose & Treat → Follo
Slide 23: Strong execution, demonstrated results
Strong execution, demonstrated results Results observed across agilon’s embedded programs, partner relationships, and PCP execution 10% 24% 8% 87 Lower hospital Lower readmission rate Lower emergency room Patient satisfaction admissions1 (readmit) 1 utilization (ED) 1 (NPS) 1 For agilon MA patients
Slide 24: Future pathway creation balances opportunity and complexity
Future pathway creation balances opportunity and complexity while considering time to impact1 A disciplined roadmap: expanding our care model to additional complex care conditions while enhancing existing pathways to improve patient outcomes 1 Enhance current pathways Optimize existing programs to i
Slide 25: Focus area: Physician Engagement
Focus area: Physician Engagement Dr. Jon Copeland Family Physician, United Physicians Copyright © 2026 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Slide 26: Proactive management: aligning status with clinical focus
Proactive management: aligning status with clinical focus to understand and act on patient trajectory SERIOUS ILLNESS CARE 5% Manage complexity – serious illness care HIGH Change trajectory – prevent further decline, RISK 10% protect quality of life RISING RISK 40% Early intervention – alter traject
Slide 27: Proactive management: how it works
Proactive management: how it works Identify Intervene Reassess PCPs and multidisciplinary Individualized 90-day action Patients exit intensive care teams convene regularly to plans are built for intervention management only when review high-needs members across 6 primary domains: certain criteria ar
Slide 28: Inside a review: proactive management in practice
Inside a review: proactive management in practice Adapted example of the review process Action Plan Initial Date of Needs Needs Health PCP Visit Needs Needs Med Discussion Most Recent Palliative/ Condition Notes/Action Plans Trajectory Frequency CM Review Date Discussion Hospice Review Utilization r
Slide 29: Focus area: Quality Programs
Focus area: Quality Programs Heidi Hittner Chief Business Operations Officer, agilon health Dr. Jon Copeland Family Physician, United Physicians Copyright © 2026 agilon health. Confidential internal document containing proprietary information. Do not distribute.
Slide 30: Quality. Every patient. Every visit. Every opportunity.
Quality. Every patient. Every visit. Every opportunity. A value driver for patients, physicians and payors at every step in the care continuum Better Easier gap closure Stronger Stars for Value patient care for our partners payor partners differentiation Through whole-person, Care reinforced by accu
Slide 31: Blood pressure control: A major modifiable lever on CVD
Blood pressure control: A major modifiable lever on CVD The clinical case • Hypertension is one of the most common, modifiable 121.5M 670K+ drivers of cardiovascular death in the U.S. — and one of U.S. adults ≥20 have high Annual U.S. deaths with the most under-controlled. blood pressure1 hypertensi
Slide 32: A quality playbook across chronic care, prevention & experience
A quality playbook across chronic care, prevention & experience Chronic condition Reducing unnecessary Prevention Patient management hospital admissions experience • Diabetes: Hemoglobin A1C • Care Coordination to • Screenings for • Proactive patient control, annual eye exam, see patients quickly af
Slide 33: Effective condition management linked to lower utilization
Effective condition management linked to lower utilization1 Non-controlled ‘24 & ‘25 Controlled ‘24 & ‘25 High blood pressure control for patients with hypertension HbA1c control for patients with diabetes IP admissions per thousand IP admissions per thousand Controlled Controlled agilon patients ag
Slide 34: Strong quality outcomes across MA and ACO populations
Strong quality outcomes across MA and ACO populations Key Star measures1 Star Gap Closure Rate1 90% 88% 85% % Gap Closure Rate 3 85% 85% Cancer Cancer 84% 5 80% screening 79% 75% 76% 75% 70% 72% Diabetes 3 2022 2023 2024 2025 4 agilon MA Avg Chronic 3 condition Hypertension 5 management 83% 93% AWV
Slide 35: A model built to compound value for patients and partners
A model built to compound value for patients and partners As more physicians engage with agilon’s programs, partners benefit—empowering physicians to deliver higher-quality care, reducing the total cost of care, and improving outcomes for the patients who need it most. agilon delivers Stronger • Ele
Slide 36: Questions? Answers.
Questions? Answers. Copyright © 2026 agilon health. Confidential internal document containing proprietary information. Do not distribute. 36